Clinical case seminar: Hypoglycemia due to paraneoplastic secretion of insulin-like growth factor-I in a patient with metastasizing large-cell carcinoma of the lung

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 5, 2007, Pages 1600-1605

  Nauck, Michael A ^a,b   Reinecke, Manfred ^c   Perren, Aurel ^d   Frystyk, Jan ^e   Berishvili, Giorgi ^c   Zwimpfer, Cornelia ^d   Figge, Anja M ^a   Flyvbjerg, Allan ^e   Lankisch, Paul G ^f,g   Blum, Werner F ^h   Klöppel, Günter ⁱ   Schmiegel, Wolff ^a   Zapf, Jürgen ^c,d  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b DIABETESZENTRUM BAD LAUTERBERG   (Germany)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f Municipal Hospital of Lueneburg   (Germany)

^g JUSTUS LIEBIG UNIVERSITY   (Germany)

^h LILLY DEUTSCHLAND GMBH   (Germany)

ⁱ UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; DOCETAXEL; ETOPOSIDE; GEFITINIB; GEMCITABINE; GLUCOSE; HUMAN GROWTH HORMONE; INSULIN; NAVELBINE; PREDNISONE; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; ANTINEOPLASTIC AGENT; RNA;

ADULT; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CASE REPORT; CEREBELLUM TUMOR; CONFERENCE PAPER; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; GEL FILTRATION; HUMAN; HYPOGLYCEMIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARGE CELL CARCINOMA; LUNG CARCINOMA; LYMPH NODE METASTASIS; MULTIPLE CYCLE TREATMENT; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SJOEGREN SYNDROME; ARTICLE; BIOSYNTHESIS; BLOOD; ECTOPIC HORMONE PRODUCTION; GEL CHROMATOGRAPHY; GENETICS; GLUCOSE BLOOD LEVEL; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD GLUCOSE; CARBOPLATIN; CARCINOMA, LARGE CELL; CHROMATOGRAPHY, GEL; ETOPOSIDE; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYPOGLYCEMIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MIDDLE AGED; PARANEOPLASTIC ENDOCRINE SYNDROMES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 34249851195     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2573     Document Type: Conference Paper

References (30)

1. Kahn CR 1980 The riddle of tumour hypoglycaemia revisited. Clin Endocrinol Metab 9:335-360
2. Marks V, Teale JD 1991 Tumours producing hypoglycaemia. Diabetes Metab Rev 7:79-91
3. Zapf J 1995 Insulin-like growth factor binding proteins and tumor hypoglycemia. Trends Endocrinol Metab 6:37-42
4. Lloyd RV, Erickson LA, Nascimento AG, Klöppel G 1999 Neoplasms causing nonhyperinsulinemic hypoglycemia. Endocr Pathol 10:291-297
5. Le Roith D 1999 Tumor-induced hypoglycemia. N Engl J Med 341:757-758
6. Daughaday WH, Emanuelle MA, Brooks MH, Barbato AL, Kapadia M, Rotwein P 1988 Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. N Engl J Med 319:1434-1440
7. Zapf J, Futo E, Peter M, Froesch ER 1992 Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? J Clin Invest 90:2574-2584
8. Frystyk J, Skjaerbaek C, Zapf J, Ørskov H 1998 Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia. Diabetologia 41:589-594
9. Baxter RC, Holman SR, Corbould A, Stranks S, Ho PJ, Braund W 1995 Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab 80:2700-2708
10. Jakob A, Meyer UA, Flury R, Ziegler WH, Labhart A, Froesch ER 1967 The pathogenesis of tumour hypoglycaemia: blocks of hepatic glucose release and of adipose tissue lipolysis. Diabetologia 3:506-514
11. Moller N, Blum WF, Mengel A, Hansen LB, Alberti KG, Schmitz O 1991 Basal and insulin stimulated substrate metabolism in tumour induced hypoglycaemia; evidence for increased muscle glucose uptake. Diabetologia 34:17-20
12. Eastman RC, Carson RE, Orloff DG, Cochran CS, Perdue JF, Rechler MM, Lanau F, Roberts Jr CT, Shapiro J, Roth J 1992 Glucose utilization in a patient with hepatoma and hypoglycemia. Assessment by a positron emission tomography. J Clin Invest 89:1958-1963
13. Fukuda I, Hizuka N, Ishikawa Y, Yasumoto K, Murakami Y, Sata A, Morita J, Kurimoto M, Okubo Y, Takano K 2006 Clinical features of insulin-like growth factor-II producing non-islet-cell tumor hypoglycemia. Growth Horm IGF Res 16:211-216
14. Shames JM, Dhurandhar NR, Blackard WG 1968 Insulin-secreting bronchial carcinoid with widespread metastases. Am J Med 44:632-637
15. O'Neill RT, Mikuta JJ 1970 Hypoglycemia associated with serous cystadenocarcinoma of the ovary. Obstet Gynecol 35:287-289
16. Seckl MJ, Mulholland PJ, Bishop AE, Teale JD, Hales CN, Glaser M, Watkins S, Seckl JR 1999 Hypoglycemia due to an insulin-secreting small-cell carcinoma of the cervix. N Engl J Med 341:733-736
17. Zapf J, Walter H, Froesch ER 1981 Radioimmunological determination of insulin-like growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. J Clin Invest 68:1321-1330
18. Breier BH, Milsom SR, Blum WF, Schwander J, Gallaher BW, Gluckman PD 1993 Insulin-like growth factors and their binding proteins in plasma and milk after growth hormone-stimulated galactopoiesis in normally lactating women. Acta Endocrinol 129:427-435
19. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR 1990 A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 70:1292-1298
20. Zapf J, Schmid C, Guler HP, Waldvogel M, Hauri C, Futo E, Hossenlopp P, Binoux M, Froesch ER 1990 Regulation of binding proteins for insulin-like growth factors (IGF) in humans. J Clin Invest 86:952-961
21. Reinecke M, Schmid AC, Heyberger-Meyer B, Hunziker EB, Zapf J 2000 Effect of growth hormone and insulin-like growth factor I (IGF-I) on the expression of IGF-I mRNA and peptide in rat tibial growth mplate and articular chondrocytes in vivo. Endocrinology 141:2847-2853
22. Maier-Woelfle M, Brandle M, Komminoth P, Saremaslani P, Schmid S, Locher T, Heitz PU, Krull I, Galeazzi RL, Schmid C, Perren A 2004 A novel succinate dehydrogenase subunit B gene mutation, H132P, causes familial malignant sympathetic extraadrenal paragangliomas. J Clin Endocrinol Metab 89:362-367
23. Guler H-P, Zapf J, Schmid C, Froesch ER 1989 Insulin-like growth factor I and II in healthy man. Acta Endocrinol 121:753-758
24. Hussain MA, Schmitz O, Mengel A, Keller A, Christiansen JS, Zapf J, Froesch ER 1993 Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J Clin Invest 92:2249-2256
25. Bermann M, Jaffe CA, Tsai W, DeMott-Friberg R, Barkan AL 1994 Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor I. J Clin Invest 94:138-145
26. Zapf J, Hauri C, Futo E, Hussain M, Rutishauser J, Maack CA 1995 Intravenously injected insulin-like growth factor (IGF) I/IGF binding protein-3 complex exerts insulin-like effects in hypophysectomized, but not in normal rats. J Clin Invest 95:179-186
27. Binoux M, Hossenlopp P 1988 Insulin-like growth factor (IGF) and IGFbinding proteins: comparison of human serum and lymph. J Clin Endocrinol Metab 67:509-514
28. Teale JD, Blum WF, Marks V 1992 Alleviation of non-islet cell tumour hypoglycaemia by growth hormone therapy is associated with changes in IGF-binding protein-3. Ann Clin Biochem 29:314-323
29. Rizza RA, Mandarino L, Gerich JE 1982 Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31:663-669
30. Rizza RA, Mandarino LJ, Gerich JE 1982 Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab 54:131-138